ANITTA KANDARAPPALLIL: Open Payments
NPI 1154061380 · WESLEY CHAPEL, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,509 in 65 payments from 17 companies in 2025. Trend: 2023 $228 · 2024 $466 · 2025 $1,509
Food & beverage: $1,509
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $283 |
| Lilly USA, LLC | 10 | $208 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $135 |
| AstraZeneca Pharmaceuticals LP | 5 | $117 |
| Boston Scientific Corporation | 4 | $116 |
| ABBVIE INC. | 4 | $97 |
| Renalytix AI, Inc. | 4 | $96 |
| GlaxoSmithKline, LLC. | 4 | $70 |
| Amgen Inc. | 4 | $68 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $66 |
Products named: JARDIANCE, Ozempic, General - Pain Management, MOUNJARO, KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT, Wegovy, SHINGRIX, Kerendia.
Industry payments across FL — which companies pay providers there.
